Product Information
UCERIS 2 MG RECTAL FOAM is a brand product labeled by Salix Pharmaceuticals Inc., priced at $11.6277 per GM under NDC 65649065103. Its NADAC has been published 386 times since Oct 18, 2017.
FDA first approved this application on Oct 7, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Salix Pharmaceuticals Inc.NDC
65649065103
Classification
Brand
Dosage Form
AEROSOL, FOAM
Route
RECTAL
Effective Date
9/17/2025
Active Ingredients
BUDESONIDEApproval Type
New Drug (NDA)
FDA Application
NDA205613FDA Approved
10/7/2014
TE Code
AB
On Market Since
12/1/2014
Pharmacological Classes
Price Statistics
The NADAC for UCERIS 2 MG RECTAL FOAM has been published 386 times since Oct 18, 2017, and over the history we have for it it has risen 49.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.6277 per GM |
|---|---|
| All-time high | $11.7080 (Apr 16, 2025) |
| All-time low | $7.7796 (Oct 18, 2017) |
| 52-week high | $11.6277 |
| 52-week low | $11.6201 |
| Median price | $10.9243 |
| Average price | $10.3550 |
| Largest weekly change | +9.0% (Jan 17, 2018) |
| Weeks tracked | 386 |
| Tracking since | Oct 18, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.1%
3Y
-0.4%
5Y
+14.8%
All
+49.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 19% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of UCERIS 2 MG RECTAL FOAM?
The current National Average Drug Acquisition Cost (NADAC) for UCERIS 2 MG RECTAL FOAM, manufactured by Salix Pharmaceuticals Inc., is $11.6277 per GM (NDC 65649065103), effective Oct 1, 2025.
How has the price of UCERIS 2 MG RECTAL FOAM changed over time?
Over the history we have for it, the NADAC for UCERIS 2 MG RECTAL FOAM has risen 49.5%. It has been tracked across 386 weekly CMS publications since Oct 18, 2017.
What are the highest and lowest recorded NADAC prices for UCERIS 2 MG RECTAL FOAM?
Since Oct 18, 2017, the NADAC for UCERIS 2 MG RECTAL FOAM has ranged from a low of $7.7796 (Oct 18, 2017) to a high of $11.7080 (Apr 16, 2025), with a median of $10.9243 per GM.
Are there cheaper alternatives to UCERIS 2 MG RECTAL FOAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE 2 MG RECTAL FOAM, is $9.4092 per GM — about 19% below UCERIS 2 MG RECTAL FOAM.
Who manufactures UCERIS 2 MG RECTAL FOAM?
UCERIS 2 MG RECTAL FOAM (NDC 65649065103) is labeled by Salix Pharmaceuticals Inc., and CMS classifies it as a brand product.